|
|
The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer
Delphine Le Corre
,
Alexandre Ghazi
,
Ralyath Balogoun
,
Camilla Pilati
,
Thomas Aparicio
et al.
Article dans une revue
hal-02305551v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD)
Lydia Guittet
,
Valérie Quipourt
,
Thomas Aparicio
,
Elisabeth Carola
,
Jean-François Seitz
et al.
Article dans une revue
hal-03972097v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype
Alexandre Ghazi
,
Delphine Le Corre
,
Camilla Pilati
,
Julien Taieb
,
Thomas Aparicio
et al.
Article dans une revue
hal-03285118v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Astrid Lièvre
,
Anthony Turpin
,
Isabelle Ray-Coquard
,
Karine Le Malicot
,
Juliette Thariat
et al.
Article dans une revue
hal-02998283v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer
Emeric Boisteau
,
Eric François
,
Thomas Aparicio
,
Karine Le Malicot
,
Rabia Boulahssass
et al.
Article dans une revue
hal-03632563v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial.
Thomas Aparicio
,
Eric Francois
,
Laurence Cristol-Dalstein
,
Elisabeth Carola
,
Emilie Maillard
et al.
Article dans une revue
hal-01437519v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: a French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
Pierre Michel
,
Valérie Boige
,
Thierry André
,
Thomas Aparicio
,
Jean Baptiste Bachet
et al.
Article dans une revue
hal-01704109v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)
Jean Frédéric Blanc
,
Audrey Debaillon-Vesque
,
Gaël Roth
,
Jean Claude Barbare
,
Anne Sophie Baumann
et al.
Article dans une revue
hal-03612929v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)
Aziz Zaanan
,
Emmanuelle Samalin
,
Thomas Aparicio
,
Olivier Bouché
,
Pierre Laurent-Puig
et al.
Article dans une revue
hal-01917535v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
COVID-19 epidemic Proposed alternatives in the management of digestive cancers A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
Frédéric Di Fiore
,
Olivier Bouché
,
Come Lepage
,
David Sefrioui
,
Alice Gangloff
et al.
Article dans une revue
hal-02862261v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial
Philippe Merle
,
Jean-Frédéric Blanc
,
Julien Edeline
,
Karine Le Malicot
,
Manon Allaire
et al.
Article dans une revue
hal-04016442v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)
Christophe Locher
,
Blaise Batumona
,
Pauline Afchain
,
Nicolas Carrère
,
Emmanuelle Samalin
et al.
Article dans une revue
hal-01708040v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PRODIGE 34-FFCD 1402-ADAGE Adjuvant chemotherapy in elderly patients ă with resected stage III colon cancer: A randomized phase 3 trial
Thomas Aparicio
,
Eric Francois
,
Laurence Cristol-Dalstein
,
Elisabeth Carola
,
Emilie Maillard
et al.
Digestive and Liver Disease, 2016, 48 (2), pp.206-207
Article dans une revue
hal-01482514v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer
Adrien Guilloteau
,
Michal Abrahamowicz
,
Olayide Boussari
,
Valérie Jooste
,
Thomas Aparicio
et al.
Article dans une revue
inserm-03314999v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer
Camille Evrard
,
Christophe Louvet
,
Farid El Hajbi
,
Frédéric Di Fiore
,
Karine Le Malicot
et al.
Article dans une revue
hal-03102304v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)
David Tougeron
,
Pierre Michel
,
Astrid Lièvre
,
Michel Ducreux
,
Sébastien Gaujoux
et al.
Article dans une revue
hal-03102287v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)
Alexandra Lapeyre-Prost
,
Simon Pernot
,
Julie Sigrand
,
Karine Le Malicot
,
Florence Mary
et al.
Article dans une revue
hal-03284418v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma
Julie Niogret
,
Emeric Limagne
,
Marion Thibaudin
,
Julie Blanc
,
Aurelie Bertaut
et al.
Article dans une revue
hal-03284403v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
Jean-Claude Barbare
,
Olivier Bouché
,
Franck Bonnetain
,
Laetitia Dahan
,
Catherine Lombard-Bohas
et al.
Article dans une revue
hal-00515746v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|